Collection 2018/0910

Start date: 26.02.2018

Original article

Raphael E. Steiner, Robert Kridel, Emiliano Giostra, Thomas A. McKee, RitaAchermann, Nicolas J. Mueller, Oriol Manuel, Michael Dickenmann, Macé M. Schuurmans, Laurence de Leval, Thomas Fehr, Marianne Tinguely, Isabelle Binet, Sergio Cogliatti, Eugenia Haralamvieva, Michael Koller, the Swiss Transplant Cohort Study (STCS), Pierre-Yves Dietrich

Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland

Swiss Med Wkly. 2018;148:w14596

Post-transplant lymphoproliferative disorder (PTLD) is a potentially life-threatening complication of immunosuppression and oncogenic viral infections.

Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST)

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997–2016

Swiss Med Wkly. 2018;148:w14589

Federal regulations in Switzerland have made it mandatory to maintain a registry including all heamatopietic stem cell transplants performed in the country.

Verpassen Sie keinen Artikel!

close